SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer.
NCT04836520
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
SHR6390+anatrozole
Sponsor
Tianjin Medical University Cancer Institute and Hospital
Collaborators
[object Object]